PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis.

Abstract Surgical resection remains the primary treatment for gastrointestinal (GI) malignancy including early-stage cancer. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been reported to have beneficial clinical and immune-modulating effects in the prognosis of GI cancer patients undergoing surgery.
PMID
Related Publications

What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials.

Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients.

Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact.

Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials.

Immunonutrition Support for Patients Undergoing Surgery for Gastrointestinal Malignancy: Preoperative, Postoperative, or Perioperative? A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors

Mayor MeshTerms
Keywords

Gastrointestinal malignancy

Immune function

Omega-3 fatty acids

Postoperative complications

Journal Title bmc cancer
Publication Year Start




PMID- 28410575
OWN - NLM
STAT- MEDLINE
DA  - 20170415
DCOM- 20170418
LR  - 20170418
IS  - 1471-2407 (Electronic)
IS  - 1471-2407 (Linking)
VI  - 17
IP  - 1
DP  - 2017 Apr 14
TI  - Effects of omega-3 fatty acids on patients undergoing surgery for
      gastrointestinal malignancy: a systematic review and meta-analysis.
PG  - 271
LID - 10.1186/s12885-017-3248-y [doi]
AB  - BACKGROUND: Surgical resection remains the primary treatment for gastrointestinal
      (GI) malignancy including early-stage cancer. Omega-3 polyunsaturated fatty acids
      (n-3 PUFAs) have been reported to have beneficial clinical and immune-modulating 
      effects in the prognosis of GI cancer patients undergoing surgery. METHODS: We
      searched PubMed, Embase, EBSCO-Medline, Cochrane Central Register of Controlled
      Trials (CENTRAL), CNKI and Wanfang to identify primary research reporting the
      effects of n-3 PUFAs compared with isocaloric nutrition on GI cancer patients who
      underwent surgery up to the end of June 30, 2016. Two authors independently
      reviewed and selected eligible randomized controlled trials (RCTs). RESULTS: A
      total of 9 RCTs (623 participants) were included. The n-3 PUFAs regime resulted
      in lower levels of C-reactive protein (CRP) (P < 0.05), interleukin-6 (IL-6) (P <
      0.01), and higher levels of albumin (ALB), CD3+ T cells, CD4+ T cells and
      CD4+/CD8+ ratio (P < 0.05) compared with the isocaloric nutrition regime.
      However, there was no significant difference in the level of tumor necrosis
      factor-alpha (TNF-alpha) between the n-3 PUFAs regime and the isocaloric
      nutrition regime (P = 0.17). And the level of CD8 + T cells decreased compared
      with the isocaloric nutrition regime (P < 0.0001). CONCLUSIONS: Our meta-analysis
      revealed that n-3 PUFAs are effective in improving the nutritional status and
      immune function of GI cancer patients undergoing surgery as they effectively
      enhance immunity and attenuate the inflammatory response.
FAU - Yu, Jing
AU  - Yu J
AD  - Department of Oncology, Beijing Friendship Hospital, Capital Medical University, 
      No. 95 Yong An Road, Xicheng District, Beijing, 100050, China.
      [email protected]
FAU - Liu, Lian
AU  - Liu L
AD  - Department of Oncology, Beijing Friendship Hospital, Capital Medical University, 
      No. 95 Yong An Road, Xicheng District, Beijing, 100050, China.
FAU - Zhang, Yue
AU  - Zhang Y
AD  - Department of Oncology, Beijing Friendship Hospital, Capital Medical University, 
      No. 95 Yong An Road, Xicheng District, Beijing, 100050, China.
FAU - Wei, Jia
AU  - Wei J
AD  - Department of Oncology, Beijing Friendship Hospital, Capital Medical University, 
      No. 95 Yong An Road, Xicheng District, Beijing, 100050, China.
FAU - Yang, Fan
AU  - Yang F
AD  - Department of Oncology, Beijing Friendship Hospital, Capital Medical University, 
      No. 95 Yong An Road, Xicheng District, Beijing, 100050, China.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
DEP - 20170414
PL  - England
TA  - BMC Cancer
JT  - BMC cancer
JID - 100967800
RN  - 0 (Fatty Acids, Omega-3)
SB  - IM
MH  - Fatty Acids, Omega-3/*administration & dosage
MH  - Gastrointestinal Neoplasms/*diet therapy/metabolism/*surgery
MH  - Humans
MH  - Randomized Controlled Trials as Topic
PMC - PMC5391568
OTO - NOTNLM
OT  - *Gastrointestinal malignancy
OT  - *Immune function
OT  - *Omega-3 fatty acids
OT  - *Postoperative complications
EDAT- 2017/04/16 06:00
MHDA- 2017/04/19 06:00
CRDT- 2017/04/16 06:00
PHST- 2016/10/13 [received]
PHST- 2017/03/31 [accepted]
AID - 10.1186/s12885-017-3248-y [doi]
AID - 10.1186/s12885-017-3248-y [pii]
PST - epublish
SO  - BMC Cancer. 2017 Apr 14;17(1):271. doi: 10.1186/s12885-017-3248-y.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>